Search research articles
Contact Us
Filters
Showing results (71-80 of 140) with videos related to
Page
of 14
Sort By:
Cancer Treatment Reports
|
September 1, 1987
Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma
S Wadler, M Subar, M D Green, et al.
The Cancer Journal From Scientific American
|
August 5, 1998
Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991
S Wadler, M Atkins, D Karp, et al.
Investigational New Drugs
|
May 1, 1991
Working conference on biomodulator and chemotherapy combination therapies
T D Brown, M S Mitchell, R Pazdur, et al.
Biochemical Pharmacology
|
October 23, 1997
Measurement of deoxyuridine triphosphate and thymidine triphosphate in the extracts of thymidylate synthase-inhibited cells using a modified DNA polymerase assay
R W Horowitz, H Zhang, E L Schwartz, et al.
The Cancer Journal From Scientific American
|
November 5, 1997
Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292)
S Wadler, R Bajaj, D Neuberg, et al.
Cancer Research
|
March 15, 1994
Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase
E L Schwartz, N Baptiste, C J O'Connor, et al.
The Cancer Journal From Scientific American
|
November 17, 1998
Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma
S Wadler, H Haynes, A Rozenblit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1997
Combination therapy with 5-fluorouracil and IFN-alpha2a induces a nonrandom increase in DNA fragments of less than 3 megabases in HT29 colon carcinoma cells
R W Horowitz, B G Heerdt, X Hu, et al.
American Journal of Clinical Oncology
|
August 10, 1999
Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus
S Damle, J J Beitler, H Haynes, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
April 3, 2001
Histone acetylation and the cell-cycle in cancer
C Wang, M Fu, S Mani, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 140) with videos related to
Sort By:
Page
of 14
Cancer Treatment Reports
|
September 1, 1987
Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma
S Wadler, M Subar, M D Green, et al.
The Cancer Journal From Scientific American
|
August 5, 1998
Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991
S Wadler, M Atkins, D Karp, et al.
Investigational New Drugs
|
May 1, 1991
Working conference on biomodulator and chemotherapy combination therapies
T D Brown, M S Mitchell, R Pazdur, et al.
Biochemical Pharmacology
|
October 23, 1997
Measurement of deoxyuridine triphosphate and thymidine triphosphate in the extracts of thymidylate synthase-inhibited cells using a modified DNA polymerase assay
R W Horowitz, H Zhang, E L Schwartz, et al.
The Cancer Journal From Scientific American
|
November 5, 1997
Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292)
S Wadler, R Bajaj, D Neuberg, et al.
Cancer Research
|
March 15, 1994
Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase
E L Schwartz, N Baptiste, C J O'Connor, et al.
The Cancer Journal From Scientific American
|
November 17, 1998
Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma
S Wadler, H Haynes, A Rozenblit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 1, 1997
Combination therapy with 5-fluorouracil and IFN-alpha2a induces a nonrandom increase in DNA fragments of less than 3 megabases in HT29 colon carcinoma cells
R W Horowitz, B G Heerdt, X Hu, et al.
American Journal of Clinical Oncology
|
August 10, 1999
Phase I-II study of 5-fluorouracil, recombinant interferon alpha2a, and cisplatin in combination with external beam radiation therapy followed by surgery in patients with locally advanced carcinoma of the esophagus
S Damle, J J Beitler, H Haynes, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
April 3, 2001
Histone acetylation and the cell-cycle in cancer
C Wang, M Fu, S Mani, et al.
Page
of 14